Urimar-T (Marnel Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Urimar-T drug offered from Marnel Pharmaceutical, Inc.. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Marnel Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| SUBSTANCE NAME: | METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2005-07-22 |
| END MARKETING DATE: | 0000-00-00 |
Urimar-T HUMAN PRESCRIPTION DRUG Details:
| Item Description | Urimar-T from Marnel Pharmaceutical, Inc. |
| LABELER NAME: | Marnel Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 120; 40.8; 36.2; 10.8; .12(mg/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2005-07-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0682-0334_46155690-3be4-426c-bf32-45b860d2d25e |
| PRODUCT NDC: | 0682-0334 |
| APPLICATION NUMBER: | |
Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
